Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nob Hill Therapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Nob Hill Therapeutics

Nob Hill Therapeutics

Angel

Nob Hill Therapeutics develops and markets DryNeb, a compact, handheld nebulizer for targeted pulmonary drug delivery.

HQ
Albuquerque, NM, US
Founded
2016
Overview
Compare
Fundraising
Employees

Nob Hill Therapeutics is a Delaware Corporation, founded to develop and market DryNeb, a first-in-kind dry powder nebulizer to address large pulmonary drug delivery market opportunities. The company has exclusively licensed the technology from the University of New Mexico. DryNeb™ vs. Aerosol Mist Nebulizers Compact, handheld, portable DryNeb will replace cumbersome aerosol mist nebulizers.

The pulmonary route of drug delivery has been gaining much importance in the present day, as it enables targeted drug delivery directly to the lungs for both local and systemic treatment. Pulmonary drug delivery, as a noninvasive drug administration method, is characterized by its high bioavailability and fast action. It is increasingly used in modern clinical practice for improved treatment of local as well as systemic diseases.

Nob Hill Therapeutics - Similar Companies

Respira Therapeutics logo

Respira Therapeutics

NMB Therapeutics logo

NMB Therapeutics

Nasus Medical logo

Nasus Medical

nasusmedical.com

NovaDel Pharma logo

NovaDel Pharma

Caddo Medical Technologies logo

Caddo Medical Technologies

caddomedical.com

KelSie Biotech logo

KelSie Biotech

kel-sie.com

Microneb logo

Microneb

microneb.com

convexity scientific logo

convexity scientific

TFF Pharmaceuticals logo

TFF Pharmaceuticals

tffpharma.com

Miist Therapeutics logo

Miist Therapeutics

mymiist.com

Aero Therapeutics logo

Aero Therapeutics

Qnovia logo

Qnovia

qnovia.com

Nimbus Health logo

Nimbus Health

nimbushealth.com

Respirics logo

Respirics

Niche Biomedical logo

Niche Biomedical

Nob Hill Therapeutics - Quick Facts

Who are Nob Hill Therapeutics' competitors?

Companies similar to Nob Hill Therapeutics include Respira Therapeutics, NMB Therapeutics, Nasus Medical and NovaDel Pharma.

When was Nob Hill Therapeutics founded?

Nob Hill Therapeutics was founded in 2016.

Where is Nob Hill Therapeutics' headquarters located?

Nob Hill Therapeutics' headquarters is located in Albuquerque, NM, US.

When was Nob Hill Therapeutics' last funding round?

Nob Hill Therapeutics' most recent funding round was for $25k (USD) in March 2022.

How much has Nob Hill Therapeutics raised to-date?

As of Mar 31, 2022, Nob Hill Therapeutics has raised a total of $167.5k (USD).

How many employees does Nob Hill Therapeutics have?

Nob Hill Therapeutics has 6 employees as of Feb 5, 2024.

Nob Hill Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Medical Devices
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified